Keratin is the key structural material making up the outermost layer of our skin. In addition to its vital role as a physical structure, research into keratin function at some of the world's leading medical universities has identified the crucial biological role that keratin proteins play in the wound healing process.
Keraplast’s Replicine keratin technology has captured, for the first time, the native form and function of keratin proteins.
Based on an extensive international research program, and a strong evidence base of efficacy in wound healing, Keraplast has developed three advanced wound healing products to deliver Replicine™ Functional Keratin™ technology to the wound bed and manage a broad range of wound types, including:
- Pressure (stage I-IV) and venous stasis ulcers
- Ulcers caused by mixed vascular etiologies
- Diabetic Ulcers
- Donor sites and grafts
- First and second degree burns
- Severe sunburns
- Superficial injuries, cuts, abrasions and surgical wounds
 |
 |
Keraplast Advanced Wound Healing Products
Evidence based wound care
Keraplast advanced wound healing products are founded on extensive research and an ongoing clinical program across a range of wound types. Find out more.
Keragel T
- Formulated for convenient application to delicate skin, keragel T is used in the management of the skin disorder epidermolysis bullosa (EB).
More information about Keragel T for EB families and clinicians.
Keragel
-
Keragel is a keratin-rich gel designed for chronic dry wounds, acute wounds and skin disorders. Keragel provides moisture to a dry wound as well as a keratin environment to encourage cell growth, leading to an excellent healing outcome.
Keramatrix
-
Keramatrix is a robust keratin matrix designed for medium exudate wounds, or for use as an interface with negative pressure wound therapy. As the wound heals the keramatrix is absorbed into the wound area and does not need to be removed at dressing change.
Kerasorb
-
Kerasorb is a multilayer dressing with a keratin wound contact surface backed by a highly absorbent polyurethane foam. Designed for highly exudating wounds, Kerasorb provides keratin to the wound surface while effectively managing wound exudate.
Regulatory Approvals
Keraplast advanced wound healing products are approved by regulatory agencies in several major regions of the world including:
- US FDA
- European Union through the CE mark system
- Australian TGA
- New Zealand Medsafe
Keraplast advanced wound healing products have the CE mark and are produced in dedicated manufacturing facilities certified by TUV SUD to the international medical device standard ISO 13485.
